![AML-5: Exploring a role for HARMONY data as historical control in elderly Acute Myeloid Leukemia patients. - HARMONY Alliance AML-5: Exploring a role for HARMONY data as historical control in elderly Acute Myeloid Leukemia patients. - HARMONY Alliance](https://www.harmony-alliance.eu/webimages/CONTENT%202021-1/PROJECTS/Afbeelding1.jpg)
AML-5: Exploring a role for HARMONY data as historical control in elderly Acute Myeloid Leukemia patients. - HARMONY Alliance
![The Leukemia & Lymphoma Society's Presence at ASH Showcases Progress to Advance Cures and Care for Blood Cancer Patients The Leukemia & Lymphoma Society's Presence at ASH Showcases Progress to Advance Cures and Care for Blood Cancer Patients](https://mma.prnewswire.com/media/808561/Leukemia_Lymphoma_Society_Logo.jpg)
The Leukemia & Lymphoma Society's Presence at ASH Showcases Progress to Advance Cures and Care for Blood Cancer Patients
![Foundation for the National Institutes of Health on Twitter: "Relapse is a major obstacle to recovery from acute myeloid leukemia (AML). The Biomarkers Consortium announces a project validating measurable residual disease (MRD) Foundation for the National Institutes of Health on Twitter: "Relapse is a major obstacle to recovery from acute myeloid leukemia (AML). The Biomarkers Consortium announces a project validating measurable residual disease (MRD)](https://pbs.twimg.com/media/FLFfeWjUYAgLofF.jpg:large)
Foundation for the National Institutes of Health on Twitter: "Relapse is a major obstacle to recovery from acute myeloid leukemia (AML). The Biomarkers Consortium announces a project validating measurable residual disease (MRD)
![Secondary Acute Myeloid Leukemia, A Lethal Disease: Ground-breaking Research Supported By Alwaleed Bin Talal Foundation-Global 2023 - EORTC Secondary Acute Myeloid Leukemia, A Lethal Disease: Ground-breaking Research Supported By Alwaleed Bin Talal Foundation-Global 2023 - EORTC](https://www.eortc.org/app/uploads/2014/03/alwaleed2.png)
Secondary Acute Myeloid Leukemia, A Lethal Disease: Ground-breaking Research Supported By Alwaleed Bin Talal Foundation-Global 2023 - EORTC
![New directions for emerging therapies in acute myeloid leukemia: the next chapter | Blood Cancer Journal New directions for emerging therapies in acute myeloid leukemia: the next chapter | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-020-00376-1/MediaObjects/41408_2020_376_Fig1_HTML.png)
New directions for emerging therapies in acute myeloid leukemia: the next chapter | Blood Cancer Journal
![Study Shows Acute Myeloid Leukemia Patients Who Participated in Upfront Genomic Testing Had Superior Treatment and Survival Outcomes Study Shows Acute Myeloid Leukemia Patients Who Participated in Upfront Genomic Testing Had Superior Treatment and Survival Outcomes](https://cancer.osu.edu/-/media/images/shared/media-room/cancer/press-releases/2016/october/lls-partner-logos-graphic.jpg)